A Review of Computational Methods in Predicting hERG Channel Blockers

被引:3
|
作者
Shan, Mengyi [1 ]
Jiang, Chen [2 ]
Qin, Lu-Ping [1 ]
Cheng, Gang [1 ]
机构
[1] Zhejiang Chinese Med Univ, Sch Pharmaceut Sci, Hangzhou 310053, Peoples R China
[2] QuanMin RenZheng HangZhou Technol Co Ltd, Hangzhou, Peoples R China
来源
CHEMISTRYSELECT | 2022年 / 7卷 / 31期
关键词
hERG; Inhibitors; Ligand-based; Machine Learning; Virtual Screening; VECTOR MACHINE METHOD; POTASSIUM CHANNEL; K+ CHANNEL; BIG DATA; CLASSIFICATION MODELS; CRYSTAL-STRUCTURE; ADMET EVALUATION; DRUG DISCOVERY; BINDING; QSAR;
D O I
10.1002/slct.202201221
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Inhibition of the human ether-a-go-go-related gene (hERG) ion channel may lead to prolonged QT interval and even fatal ventricular arrhythmia. Therefore, evaluating the hERG liability has become a mandatory requirement for drug development and drug safety process. However, standard experimental assays are complex, expensive and time-consuming. Various in silico tools have been developed to identify potential hERG blockers and reduce in advance the risk of cardiotoxicity-related attritions during the early drug discovery phase. In this review, we first outlined the structure and gating properties of the hERG channel briefly. Then analyzed the advantages of computational technology, and comprehensively summarized the in silico methods of hERG-related cardiotoxicity, including ligand-based and structure-based methods. Additionally, the current predictive models in prediction of hERG blockage were emphatically reviewed. Finally, issues involved in the current computational methods, as well as the future direction for developing reliable models of hERG channel blockers, are discussed.
引用
下载
收藏
页数:11
相关论文
共 50 条
  • [41] Identifying hERG potassium channel inhibitors by machine learning methods
    Wang, Min
    Yang, Xue-Gang
    Xue, Ying
    QSAR & COMBINATORIAL SCIENCE, 2008, 27 (08): : 1028 - 1035
  • [42] Do hERG Enhancers and Blockers Compete?
    Liu, Xiaoqin
    Limberis, James T.
    Su, Zhi
    Houseman, Kathryn A.
    Diaz, Gilbert J.
    Gintant, Gary A.
    Cox, Bryan F.
    Martin, Ruth L.
    BIOPHYSICAL JOURNAL, 2009, 96 (03) : 263A - 263A
  • [43] Exploring QSTR and toxicophore of hERG K+ channel blockers using GFA and HypoGen techniques
    Garg, Divita
    Gandhi, Tamanna
    Mohan, C. Gopi
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2008, 26 (06): : 966 - 976
  • [44] Predictive models for hERG channel blockers: Ligand-based and structure-based approaches
    Thai, Khac-Minh
    Ecker, Gerhard F.
    CURRENT MEDICINAL CHEMISTRY, 2007, 14 (28) : 3003 - 3026
  • [45] Investigating cardiotoxicity related with hERG channel blockers using molecular fingerprints and graph attention mechanism
    Wang, Tianyi
    Sun, Jianqiang
    Zhao, Qi
    COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 153
  • [46] Cardiac hERG channel blockers sensitize human glioblastoma cells towards the genotoxic effects of temozolomide
    Knoedler, L.
    Roth, I.
    Wos-Maganga, M.
    Weickhardt, S.
    Vogel, M.
    Haas, B.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (SUPPL 1) : S15 - S15
  • [47] Computational Tool for Fast in silico Evaluation of hERG K+ Channel Affinity
    Chemi, Giulia
    Gemma, Sandra
    Campiani, Giuseppe
    Brogi, Simone
    Butini, Stefania
    Brindisi, Margherita
    FRONTIERS IN CHEMISTRY, 2017, 5
  • [48] HERG channel blockers can act as chemical chaperones to correct defective protein trafficking of HERG mutations in human long QT syndrome.
    Zhou, ZF
    Gong, QM
    January, CT
    BIOPHYSICAL JOURNAL, 2000, 78 (01) : 341A - 341A
  • [49] Characterization of A-935142, a hERG enhancer, in the presence and absence of standard hERG blockers
    Liu, Xiaoqin
    Limberis, James T.
    Su, Zhi
    Houseman, Kathryn
    Diaz, Gilbert J.
    Gintant, Gary A.
    Cox, Bryan F.
    Martin, Ruth L.
    LIFE SCIENCES, 2012, 90 (15-16) : 607 - 611
  • [50] Prediction of hERG potassium channel affinity by traditional and hologram QSAR methods
    Keserü, GM
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (16) : 2773 - 2775